BioNTech SE Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	23,460	26,387	22,698	34,159	54,749	16,047
Market Cap Growth	-16.70%	16.25%	-33.55%	-37.61%	241.19%	134.91%
Enterprise Value	9,236	8,649	7,810	22,089	52,601	15,236
Last Close Price	93.50	108.70	95.00	144.05	211.93	71.90
PE Ratio	-	-	24.40	3.62	5.32	1055.70
PS Ratio	7.44	9.59	5.94	1.97	2.89	33.27
PB Ratio	1.27	1.36	1.12	1.70	4.60	11.70
P/TBV Ratio	1.40	1.45	1.19	1.72	4.68	13.22
P/FCF Ratio	-	-	4.43	2.58	71.83	-
P/OCF Ratio	-	127.04	4.23	2.52	61.54	-
EV/Sales Ratio	2.94	3.14	2.05	1.28	2.77	31.59
EV/EBITDA Ratio	-	-	7.04	1.84	3.53	-
EV/EBIT Ratio	-	-	8.04	1.85	3.54	-
EV/FCF Ratio	-18.65	-	1.53	1.67	69.01	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.03	0.18
Debt / EBITDA Ratio	-	-	0.19	0.02	0.02	-
Debt / FCF Ratio	-	-	0.04	0.02	0.40	-
Net Debt / Equity Ratio	-0.77	-0.85	-0.81	-0.69	-0.15	-0.81
Net Debt / EBITDA Ratio	30.53	16.00	-14.71	-1.16	-0.12	3.83
Net Debt / FCF Ratio	28.84	209.76	-3.19	-1.05	-2.33	13.93
Asset Turnover	0.14	0.12	0.17	0.89	2.09	0.31
Inventory Turnover	2.09	1.69	1.51	6.36	10.28	1.56
Quick Ratio	6.89	7.26	9.12	7.19	4.15	2.50
Current Ratio	7.12	7.45	9.43	7.43	4.33	2.75
Return on Equity (ROE)	-3.04%	-3.36%	4.62%	59.06%	155.18%	1.63%
Return on Assets (ROA)	-2.30%	-3.53%	2.62%	38.09%	102.25%	-12.89%
Return on Invested Capital (ROIC)	-18.04%	-37.82%	15.07%	106.34%	195.58%	-206.44%
Return on Capital Employed (ROCE)	-4.20%	-6.40%	4.60%	58.60%	120.20%	-18.80%
Earnings Yield	-2.44%	-2.52%	4.10%	27.62%	18.80%	0.10%
FCF Yield	-2.11%	-0.30%	22.56%	38.78%	1.39%	-0.50%
Buyback Yield / Dilution	0.40%	0.95%	2.84%	3.81%	-4.51%	-17.49%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.